• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 3 filed by new insider Mckeage Jonathan F

    8/25/23 5:25:22 PM ET
    $FTII
    Blank Checks
    Finance
    Get the next $FTII alert in real time by email
    SEC FORM 3 SEC Form 3
    FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0104
    Estimated average burden
    hours per response: 0.5
    1. Name and Address of Reporting Person*
    McKeage Jonathan F

    (Last) (First) (Middle)
    128 GAIL DRIVE

    (Street)
    NEW ROCHELLE NY 10805

    (City) (State) (Zip)
    2. Date of Event Requiring Statement (Month/Day/Year)
    08/18/2023
    3. Issuer Name and Ticker or Trading Symbol
    FutureTech II Acquisition Corp. [ FTII ]
    4. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    X Director 10% Owner
    Officer (give title below) Other (specify below)
    5. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Beneficially Owned
    1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
    Table II - Derivative Securities Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
    Date Exercisable Expiration Date Title Amount or Number of Shares
    Explanation of Responses:
    No securities are beneficially owned.
    /s/ Jonathan McKeage, by Nelson Mullins Riley & Scarborough LLP with Power of Attorney 08/25/2023
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $FTII alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $FTII

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $FTII
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    FutureTech II Acquisition Corp. Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Quarterly Reports on Form 10-Q and Publicly Held Shares Rule and Makes Progress Towards Regaining Compliance

    New York, New York, Dec. 04, 2024 (GLOBE NEWSWIRE) -- FutureTech II Acquisition Corp. (the "Company") (NASDAQ:FTII), today announced that it received an expected deficiency notification letter from the staff (the "Staff") of The Nasdaq Stock Market LLC ("Nasdaq") on November 27, 2024 (the "Notice"). The Notice indicated that the Company was not in compliance with Nasdaq Listing Rule 5250(c)(1) as a result of its failure to timely file its Quarterly Report on Form 10-Q for the quarter ended September 30, 2024 (the "Q3 10-Q"), as described more fully in the Company's Form 12b-25 Notification of Late Filing filed with the Securities and Exchange Commission (the "SEC") on November 15, 2024. Th

    12/4/24 1:35:00 PM ET
    $FTII
    Blank Checks
    Finance

    Longevity Biomedical, Inc. and FutureTech II Acquisition Corp. Announce Business Combination to Create Nasdaq-Listed Biopharmaceutical Company Focused on Advancing New Technologies to Promote Human Health and Longevity

     -Longevity Biomedical, Inc. is focused on developing and acquiring new technologies spanning therapeutics, health monitoring and digital health solutions to become a leading provider of longevity-related products and services designed to increase the health span for the rapidly growing global aging population.    -Late-stage, diversified pipeline of therapeutic candidates across ophthalmology, cardiovascular disease and soft tissue reconstruction and repair.    -Near-term clinical milestones include Phase 3 start for LBI-201 for Ischemic stroke, Phase 2 data for LBI-101 for soft-tissue reconstruction, and Phase 2 start for LBI-001 in retinal vein occlusion.    -Seasoned management team of m

    9/20/24 2:55:00 PM ET
    $FTII
    Blank Checks
    Finance

    FutureTech II Acquisition Corp. Confirms Funding and Extension of Period to Complete Initial Business Combination

    New Rochelle, NY, May 17, 2023 (GLOBE NEWSWIRE) -- FutureTech II Acquisition Corp. (NASDAQ:FTIIU) (the "Company"), a blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses, announced today that it caused to be deposited $1,150,000 into the Company's trust account for its public stockholders, representing $0.10 per public share, allowing the Company to extend by three months (from May 18, 2023 to August 18, 2023) the period of time the Company has to consummate its initial business combination (the "Extension"). The Extension is the second of two

    5/17/23 4:05:00 PM ET
    $FTII
    Blank Checks
    Finance

    $FTII
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    CEO & CFO Chen Ray Lei converted options into 380,000 shares (SEC Form 4)

    4 - FutureTech II Acquisition Corp. (0001889450) (Issuer)

    2/6/25 8:42:18 PM ET
    $FTII
    Blank Checks
    Finance

    Large owner Radu Zachary C. converted options into 2,445,000 shares (SEC Form 4)

    4 - FutureTech II Acquisition Corp. (0001889450) (Issuer)

    2/6/25 6:30:25 PM ET
    $FTII
    Blank Checks
    Finance

    Director Bush Neil converted options into 10,000 shares (SEC Form 4)

    4 - FutureTech II Acquisition Corp. (0001889450) (Issuer)

    2/6/25 4:48:44 PM ET
    $FTII
    Blank Checks
    Finance

    $FTII
    SEC Filings

    View All

    SEC Form 10-Q filed by FutureTech II Acquisition Corp.

    10-Q - FutureTech II Acquisition Corp. (0001889450) (Filer)

    8/22/25 5:10:57 PM ET
    $FTII
    Blank Checks
    Finance

    FutureTech II Acquisition Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits

    8-K - FutureTech II Acquisition Corp. (0001889450) (Filer)

    8/18/25 5:26:57 PM ET
    $FTII
    Blank Checks
    Finance

    FutureTech II Acquisition Corp. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits

    8-K - FutureTech II Acquisition Corp. (0001889450) (Filer)

    8/15/25 6:41:34 PM ET
    $FTII
    Blank Checks
    Finance

    $FTII
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by FutureTech II Acquisition Corp.

    SC 13G/A - FutureTech II Acquisition Corp. (0001889450) (Subject)

    11/14/24 1:07:48 PM ET
    $FTII
    Blank Checks
    Finance

    Amendment: SEC Form SC 13G/A filed by FutureTech II Acquisition Corp.

    SC 13G/A - FutureTech II Acquisition Corp. (0001889450) (Subject)

    11/13/24 4:51:36 PM ET
    $FTII
    Blank Checks
    Finance

    SEC Form SC 13G filed by FutureTech II Acquisition Corp.

    SC 13G - FutureTech II Acquisition Corp. (0001889450) (Subject)

    11/13/24 4:41:47 PM ET
    $FTII
    Blank Checks
    Finance